Human growth hormone ( DrugBank: Growth hormone, Human growth hormone )


5 diseases
IDDisease name (Link within this page)Number of trials
78Hypopituitarism184
187Kabuki syndrome1
193Prader-Willi syndrome3
265Lipodystrophy12
276Achondroplasia1

78. Hypopituitarism


Clinical trials : 492Drugs : 341 - (DrugBank : 47) / Drug target genes : 45 - Drug target pathways : 100 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

187. Kabuki syndrome


Clinical trials : 4Drugs : 9 - (DrugBank : 2) / Drug target genes : 2 - Drug target pathways : 11 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

193. Prader-Willi syndrome


Clinical trials : 113Drugs : 111 - (DrugBank : 26) / Drug target genes : 48 - Drug target pathways : 102 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

265. Lipodystrophy


Clinical trials : 112Drugs : 155 - (DrugBank : 55) / Drug target genes : 25 - Drug target pathways : 97 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

276. Achondroplasia


Clinical trials : 51Drugs : 34 - (DrugBank : 6) / Drug target genes : 4 - Drug target pathways : 26 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries